臺灣人文及社會科學引文索引資料庫系統

:::

詳目顯示

回上一頁
第 1 筆 / 總合 1 筆   第一頁 上一頁 下一頁 最後一頁
/1頁
題名：Psychiatric Practice in the Era of Precision Medicine
書刊名：Taiwanese Journal of Psychiatry
作者：陳嘉祥
作者(外文)：Chen, Chia-hsiang
出版日期：2016
卷期：30:3
頁次：頁158-168+a7
主題關鍵詞：精準醫學；個人化醫療；基因體資訊；精準精神醫學；Precision medicine；Personalized medicine；Genomic information；Precision psychiatry
原始連結：連回原系統網址new window
相關次數：
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:6
美國於完成人類基因體計畫之後，由總統歐巴馬於2015 年1 月宣布將進行精準醫學的大型研究計畫，將個人的基因體資訊與與臨床資料進行聯結與整合，以落實個人化醫療。此計畫的執行者，美國國家衛生研究院院長說初期將以癌症為目標，長期目標則是將推廣到各種疾病。精神醫學為臨床醫學的一支，在此風潮的影響之下，將會受到一些衝擊。本綜說將精神醫學的演進放進生物醫學演進的歷史脈絡中審視，從心理學時期進入生物精神醫學，再到分子精神醫學與轉譯精神醫學，未來無可避免的會進入所謂的精準精神醫學時代。隨著醫學知識的演進，未來精神科醫師除了現有的臨床診斷外，將有更多的實驗室檢查，以幫助病因的診斷。在治療方面除了根據病因進行相關的治療外，在開藥方面也會依據病人的基因資訊，選擇療效最佳、副作用最少的藥物。這些臨床精神醫療行為的改變，當然也需醫院方面進行結構的調整，組成跨領域團隊，才能落實。
Precision medicine is the next wave of big biomedical science in the United States of America, which will continue to lead the global biomedical research after the completion of the Human Genome Project. The arrival of precision medicine is first exemplified by the development of target therapy in cancer research. The knowledge and experiences gained from cancer research will be extended to another discipline of medicine according to the statement of the Precision Medicine Initiative. Psychiatry is a discipline of medicine; the big biomedical science will certainly have an influential impact on this field. The increasing knowledge of the medical conditions causing psychiatric symptoms and the availability of the whole genome information of the patients will transform the way that psychiatrists make a diagnosis and treat the patients. In the coming era of precision psychiatry, psychiatrists will have to order more laboratory tests including genetic tests to identify the etiology of psychiatric patients, and to tailor the treatment for each patient based on his or her genetic information. But the realization of the precision psychiatric practice needs support and change of the ecosystem or infrastructure of the clinical settings. This overview elaborates some examples of those progress in psychiatry that may transform the way we practice psychiatry to some extent shortly.
期刊論文
1.McClellan, J. M.、Susser, E.、King, M. C.(2007)。Schizophrenia: a common disease caused by multiple rare alleles。Br J Psychiatry，190，194-199。  new window
2.Chung, Wen-Hung、Hung, Shuen-Iu、Hong, Hong-Shang、Hsih, Mo-Song、Yang, Li-Cheng、Ho, Hsin-Chun、Wu, Jer-Yuarn、Chen, Yuan-Tsong(2004)。Medical Genetics: A Marker for Stevens-Johnson Syndrome。Nature，428(6982)。  new window
3.Dalmau, J.、Tüzūn, E.、Wu, H. Y.(2007)。Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma。Ann Neurol，61，25-36。  new window
4.Vitaliani, R.、Mason, W.、Ances, B.、Zwerdling, T.、Jiang, Z.、Dalmau, J.(2005)。Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma。Ann Neurol，58，594-604。  new window
5.Moraes, F.、Goes, A.(2016)。A decade of human genome project conclusion: scientific diffusion about our genome knowledge。Biochem Mol Biol Educ，44，215-223。  new window
6.Manolio, T. A.、Abramowicz, M.、Al-Mulla, F.(2015)。Global implementation of genomic medicine: we are not alone。Sci Transl Med，7(290)。  new window
7.Wilson, B. J.、Nicholls, S. G.(2015)。The Human Genome Project, and recent advances in personalized genomics。Risk Manag Healthc Policy，8，9-20。  new window
8.Collins, F. S.、Varmus, H.(2015)。A new initiative on precision medicine。N Engl J Med，372，793-795。  new window
9.Scull, A.(2010)。A psychiatric revolution。Lancet，375(9722)，1246-1247。  new window
10.Coyle, J. T.(1996)。Molecules and mind: a new home for molecular research in psychiatry。Mol Psychiatry，1，5-6。  new window
11.Licinio, J.(2011)。Translational psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener。Transl Psychiatry，1。  new window
12.Insel, T. R.(2011)。A bridge to somewhere。Transl Psychiatry，1。  new window
13.Berger, J. R.、Dean, D.(2014)。Neurosyphilis。Handb Clin Neurol，121，1461-1472。  new window
14.Yanhua, W.、Haishan, S.、Le, H.(2016)。Clinical and neuropsychological characteristics of general paresis misdiagnosed as primary psychiatric disease。BMC Psychiatry，16。  new window
15.Lin, J. J.、Lin, K. L.、Hsia, S. H.(2014)。Anti-N-methyl-D-aspartate receptor encephalitis in Taiwan--a comparison between children and adults。Pediatr Neurol，50，574-580。  new window
16.Preskorn, S. H.(2016)。Personalized medicine in psychiatry: concepts for bringing associated testing into clinical practice。Mayo Clin Proc，91，827-829。  new window
17.Leypoldt, F.、Armangue, T.、Dalmau, J.(2015)。Autoimmune encephalopathies。Ann NY Acad Sci，1338，94-114。  new window
18.Barry, H.、Hardiman, O.、Healy, D. G.(2011)。Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis。Br J Psychiatry，199，508-509。  new window
19.Barry, H.、Byrne, S.、Barrett, E.、Murphy, K. C.、Cotter, D. R.(2015)。Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment。BJPsych Bull，39，19-23。  new window
20.Chapman, M. R.、Vause, H. E.(2011)。Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment。Am J Psychiatry，168，245-251。  new window
21.Dowben, J. S.、Kowalski, P. C.、Keltner, N. L.(2015)。Biological perspectives: anti-NMDA receptor encephalitis。Perspect Psychiatr Care，51，236-240。  new window
22.Chang, H. S.、Chen, P. M.、Lu, T.、Hu, L. Y.(2015)。Anti-N-methyl- D-aspartate receptor encephalitis: should psychiatrists shoulder the responsibility for a non-psychiatric disorder?。J Neurol Sci，353，189-190。  new window
23.Pollak, T. A.、Beck, K.、Irani, S. R.、Howes, O. D.、David, A. S.、McGuire, P. K.(2016)。Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications。Psychopharmacology (Berl)，233，1605-1621。  new window
24.Chefdeville, A.、Honnorat, J.、Hampe, C. S.、Desestret, V.(2016)。Neuronal CNS syndromes likely mediated by auto-antibodies。Eur J Neurosci，43，1535-1552。  new window
25.Crisp, S. J.、Kullmann, D. M.、Vincent, A.(2016)。Autoimmune synaptopathies。Nat Rev Neurosci，17，103-117。  new window
26.Linnoila, J. J.、Rosenfeld, M. R.、Dalmau, J.(2014)。Neuronal surface antibody-mediated autoimmune encephalitis。Semin Neurol，34，458-466。  new window
27.Titulaer, M. J.、McCracken, L.、Gabilondo, I.(2013)。Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study。Lancet Neurol，12，157-165。  new window
28.Graus, F.、Titulaer, M. J.、Balu, R.、Benseler, S.、Bien, C. G.、Cellucci, T.、Cortese, I.、Dale, R. C.、Gelfand, J. M.、Geschwind, M.、Glaser, C. A.、Honnorat, J.、Höftberger, R.、Iizuka, T.、Irani, S. R.、Lancaster, E.、Leypoldt, F.、Prüss, H.、Rae-Grant, A.、Dalmau, J.(2016)。A clinical approach to diagnosis of autoimmune encephalitis。The Lancet Neurology，15(4)，391-404。  new window
29.Lancaster, E.(2016)。The diagnosis and treatment of autoimmune encephalitis。J Clin Neurol，12，1-13。  new window
30.Psychiatric, GWAS Consortium Coordinating Committee、Cichon, S.、Craddock, N.(2009)。Genomewide association studies: history, rationale, and prospects for psychiatric disorders。Am J Psychiatry，166，540-556。  new window
31.Psychiatric GCSC(2009)。A framework for interpreting genome-wide association studies of psychiatric disorders。Mol Psychiatry，14(1)，10-17。  new window
32.Schizophrenia Working Group of the Psychiatric Genomics Consortium(2014)。Biological insights from 108 schizophrenia-associated genetic loci。Nature，511，421-427。  new window
33.Dima, D.、Breen, G.(2015)。Polygenic risk scores in imaging genetics: usefulness and applications。J Psychopharmacol，29，867-871。  new window
34.Santoro, M. L.、Moretti, P. N.、Pellegrino, R.(2016)。A current snapshot of common genomic variants contribution in psychiatric disorders。American Journal of Medical Genetics Part B: Neuropsychiatric Genetics，171(8)，997-1005。  new window
35.Iyegbe, C.、Campbell, D.、Butler, A.、Ajnakina, O.、Sham, P.(2014)。The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research。Soc Psychiatry Psychiatr Epidemiol，49，169-12。  new window
36.Uher, R.(2009)。The role of genetic variation in the causation of mental illness: an evolution-informed framework。Mol Psychiatry，14，1072-1082。  new window
37.Miller, D. T.、Adam, M. P.、Aradhya, S.(2010)。Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies。Am J Hum Genet，86，749-764。  new window
38.Battaglia, A.、Doccini, V.、Bernardini, L.(2013)。Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features。Eur J Paediatr Neurol，17，589-599。  new window
39.Georgieva, L.、Rees, E.、Moran, J. L.(2014)。De novo CNVs in bipolar affective disorder and schizophrenia。Hum Mol Genet，23，6677-6683。  new window
40.Gershon, E. S.、Alliey-Rodriguez, N.(2013)。New ethical issues for genetic counseling in common mental disorders。Am J Psychiatry，170，968-976。  new window
41.Schreiber, M.、Dorschner, M.、Tsuang, D.(2013)。Next-generation sequencing in schizophrenia and other neuropsychiatric disorders。American Journal of Medical Genetics Part B: Neuropsychiatric Genetics，162(7)，671-678。  new window
42.Kato, T.(2015)。Whole genome/exome sequencing in mood and psychotic disorders。Psychiatry Clin Neurosci，69，65-76。  new window
43.Buxbaum, J. D.、Daly, M. J.、Devlin, B.(2012)。The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders。Neuron，76，1052-1056。  new window
44.Sener, E. F.、Canatan, H.、Ozkul, Y.(2016)。Recent advances in autism spectrum disorders: applications of whole exome sequencing technology。Psychiatry Investig，13，255-264。  new window
45.Shinozaki, G.、Potash, J. B.(2014)。New developments in the genetics of bipolar disorder。Curr Psychiatry Rep，16。  new window
46.Gelernter, J.(2015)。Genetics of complex traits in psychiatry。Biol Psychiatry，77，36-42。  new window
47.Nassan, M.、Nicholson, W. T.、Elliott, M. A.、Rohrer Vitek, C. R.、Black, J. L.、Frye, M. A.(2016)。Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: a template for psychiatric precision medicine。Mayo Clin Proc，91，897-907。  new window
48.Oedegaard, K. J.、Alda, M.、Anand, A.(2016)。The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample。BMC Psychiatry，16。  new window
49.Hou, L.、Heilbronner, U.、Degenhardt, F.(2016)。Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study。Lancet，387，1085-1093。  new window
50.Fabbri, C.、Crisafulli, C.、Calabrò, M.、Spina, E.、Serretti, A.(2016)。Progress and prospects in pharmacogenetics of antidepressant drugs。Expert Opinion on Drug Metabolism & Toxicology，12(10)，1157-1168。  new window
51.李敏秀(20160600)。Pharmacogenetics of Antidepressants: Is There a Magic Bullet for Treating Depression?。Taiwanese Journal of Psychiatry，30(2)，79-90+a6。new window  new window
52.Koga, A. T.、Strauss, J.、Zai, C.、Remington, G.、De Luca, V.(2016)。Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study。J Neural Transm，123，329-338。  new window
53.Sriretnakumar, V.、Huang, E.、Muller, D. J.(2015)。Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update。Expert Opin Drug Metab Toxicol，11，1709-1731。  new window
54.Biernacka, J. M.、Sangkuhl, K.、Jenkins, G.(2015)。The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response。Transl Psychiatry，5。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE

臺灣人文及社會科學引文索引資料庫

目前上線人數：261（臺灣：241，外國：20） ／ 本年度總使用人次：2259778 ／ 訪客人次（自102年09月）：68058482
國家圖書館著作權聲明 Copyright © 2013 All rights reserved.
本館地址: 100201臺北市中山南路20號． 本館地圖及交通資訊．
總機：(02)23619132．最佳瀏覽解析度為1024x768以上